Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis.
Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures.
Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases.
Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis.
Glial influences on BBB functions and molecular players in immune cell trafficking.
[Neurological complications during treatment of the tumor necrosis alpha inhibitors].
Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Evaluation of Lovastatin Effects on Expression of Anti-apoptotic Nrf2 and PGC-1α Genes in Neural Stem Cells Treated with Hydrogen Peroxide.
The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.
Causes of death among persons with multiple sclerosis.
Consistent reduction in the annualized rate of brain volume loss across phase 3 core and extension trials of fingolimod in relapsing multiple sclerosis.
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
Cortisol awakening response is linked to disease course and progression in multiple sclerosis.
Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis?
How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis?
Time perception and illness acceptance among remitting-relapsing multiple sclerosis patients under treatment.
Determining disease intervention strategies using spatially resolved simulations.
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Detection of demyelination in multiple sclerosis by analysis of [Formula: see text] relaxation at 7 T.
Pharmacology and Structure of P2Y Receptors.
Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".
Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis.
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis.
Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.
Pages
« first
‹ previous
…
591
592
593
594
595
596
597
598
599
…
next ›
last »